Sumitomo Mitsui Trust Group
HALO icon

Sumitomo Mitsui Trust Group’s Halozyme HALO Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Hold
10,800
– – ﹤0.01% 901
2026
Q1 		$698K Buy
10,800
+2,300
+27% +$162K ﹤0.01% 893
2025
Q4 		$572K Buy
8,500
+4,100
+93% +$276K ﹤0.01% 930
2025
Q3 		$323K Buy
+4,400
New +$292K ﹤0.01% 1005

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group's HALO Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group held its Halozyme (HALO) position steady in Q2 2026 at 10,800 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Sumitomo Mitsui Trust Group first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 10,800 shares of Halozyme worth $845K as of Q2 2026.
  • Sumitomo Mitsui Trust Group left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #901 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.